Captafol → Dithane

HRID 1681106

Reaktionsgleichung

[Mn:1].[Zn:2].[CH2:3]([NH:9][C:10](=[S:12])[S-:11])[CH2:4][NH:5][C:6](=[S:8])[S-:7].C1C2C(N(SC(Cl)(Cl)C(Cl)Cl)C(=O)C2CC=C1)=O>>[CH2:3]([NH:9][C:10]([S-:12])=[S:11])[CH2:4][NH:5][C:6]([S-:8])=[S:7].[CH2:3]([NH:9][C:10]([S-:12])=[S:11])[CH2:4][NH:5][C:6]([S-:8])=[S:7].[Mn+2:1].[Zn+2:2]

Komponenten

Edukt 4

HCID 17038Captafol

HCID 23930Manganese

HCID 23994Zinc

HCID 4228010Ethylenebis(dithiocarbamate)

Produkt 1

HCID 3034368Dithane

Versuchsvorschrift

manganese and zinc (2.5% w/w) ethylene-bisdithiocarbamate as a wettable powder containing 80% w/w of active ingredient captafol: N-(1,1,2,2-tetrachloroethylthio)-1,2,3,6-tetrahydrophthalimide as a suspension concentrate containing 480 g./l. of active material.

Aufarbeitung

concentrationN-(1,1,2,2-tetrachloroethylthio)-1,2,3,6-tetrahydrophthalimide as a suspension concentrate
additioncontaining 480 g

Quellen und Nachweise

ORD-Eintrag: ord-fa45b408d9e14c52a5aa004be228372e
Quelldatensatz: uspto-grants-1992_12
DOI: 10.6084/m9.figshare.5104873.v1
Patentnummer: US05169646

Verknüpfte Notizen

Wird geladen…